UNSPSC 51293014: Butriptyline hydrochloride

This classification denotes an antidepressant agent with the molecular formula C21H27N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LIJ2H8658W, chemically known as 5h-dibenzo(a,d)cycloheptene-5-propylamine, 10,11-dihydro-n,n,beta-trimethyl-, hydrochloride, dl- but more generally known as butriptyline hydrochloride, which bears US NIH Compound Identifier 21771. European Medicines Agency schedules Butriptyline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00922MIG.

UNSPSC 51293014 Butriptyline hydrochloride is a Commodity code for a tricyclic antidepressant pharmaceutical product, though state and local procurement activity under this code shows a significant mismatch with the nominal pharmaceutical scope. The recent opportunity block records a single solicitation that does not reflect procurement of butriptyline hydrochloride or related antidepressants; instead, it documents Seminole County, Florida's acquisition of naloxone and drug deactivation systems for community health initiatives, which fall outside the code's stated pharmaceutical family. State and local governments do not appear to be using this code to solicit butriptyline hydrochloride or similar tricyclic antidepressants in current activity.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation closed on July 26, 2023, with bidders required to submit electronic bids through the county's e-Procurement Portal and include all shipping and delivery costs in their proposals. The contract carries a two-year initial term with a one-year renewal option, drug-free workplace and E-Verify compliance requirements, and potential FEMA funding with associated federal compliance obligations. No other state or local opportunities for this code appear in the source record. The code shows minimal relevant procurement activity; business development professionals should verify the actual commodity classification against targeted state and local health and human services solicitations if seeking to pursue pharmaceutical supply contracts.